T1	Outcomes 554 576	lipid efficacy, safety
T2	Outcomes 581 593	tolerability
T3	Outcomes 992 1026	percentage change in HDL-C levels.
T4	Outcomes 1249 1278	percent atheroma volume (PAV)
T5	Outcomes 1459 1514	lipid and inflammatory markers, safety and tolerability
T6	Outcomes 1630 1649	cardiovascular risk
